BioCentury | Jun 16, 2017
Company News

CSL buying majority stake in Chinese plasma company

...Rui De Biological Products Co. Ltd. (Ruide) for $352 million. Ruide is a subsidiary of Humanwell Healthcare...
...its CSL Behring unit held the largest share of the Chinese plasma market with 16%. Humanwell Healthcare...
...Group Co. Ltd. (Shanghai:600079), Wuhan, China CSL Ltd. (ASX:CSL), Melbourne, Australia Business: Hematology, Supply/Service Chris Lieu CSL Ltd. Humanwell Healthcare...
BioCentury | Jun 13, 2017
Company News

CSL buying majority stake in Chinese plasma company

...Rui De Biological Products Co. Ltd. (Ruide) for $352 million. Ruide is a subsidiary of Humanwell Healthcare...
...16%. On Tuesday, CSL gained A$2.60 to A$137.65, and Humanwell added RMB0.44 to RMB19.47. Chris Lieu CSL Ltd. Humanwell Healthcare...
BioCentury | Aug 8, 2016
Financial News

Ambrx completes venture financing

...completed: 2016-08-04 Type: Venture financing Raised: $45 million Investors: Apricot Capital; Northeast Securities; Sinopharm Capital; Humanwell Healthcare...
BioCentury | Aug 4, 2016
Financial News

Ambrx raises $45M

...a financing round led by Apricot Capital and Northeast Securities Prosperity Healthcare Fund. Sinopharm Capital, Humanwell Healthcare...
BioCentury | Apr 18, 2016
Company News

Epic Pharma, Humanwell Healthcare Group, PuraCap Pharmaceutical LLC deal

...this quarter. The companies did not respond to inquiries. Epic Pharma LLC , Laurelton, N.Y. Humanwell Healthcare...
BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: S. aureus

...gel, approved to treat tinea pedis. TARGET/MARKER/PATHWAY: S. aureus staphyloxanthin LICENSING STATUS: Patented; licensed to Humanwell Healthcare...
BioCentury | Apr 13, 2015
Clinical News

Remimazolam: Phase III started

...and PendoPharm has exclusive rights in Canada. Hana Pharmaceutical Co. Ltd. , Seoul, South Korea Humanwell Healthcare...
BioCentury | Nov 3, 2014
Company News

International Medica, Humanwell Healthcare Group, Shanghai BravoBio deal

...in 1999 due to concerns of incidences of intussusception. International Medica Foundation , Rochester, Minn. Humanwell Healthcare...
BioCentury | Mar 26, 2012
Company News

Paion, Humanwell Healthcare Group deal

...Paion granted Yichang Humanwell Pharmaceutical Co. Ltd., a part of Humanwell Healthcare Group, an exclusive option to...
...Ltd. (Tokyo:4528; Osaka:4528, Osaka, Japan) has Japanese rights to remimazolam. Paion AG (Xetra:PA8), Aachen, Germany Humanwell Healthcare...
Items per page:
1 - 9 of 9
BioCentury | Jun 16, 2017
Company News

CSL buying majority stake in Chinese plasma company

...Rui De Biological Products Co. Ltd. (Ruide) for $352 million. Ruide is a subsidiary of Humanwell Healthcare...
...its CSL Behring unit held the largest share of the Chinese plasma market with 16%. Humanwell Healthcare...
...Group Co. Ltd. (Shanghai:600079), Wuhan, China CSL Ltd. (ASX:CSL), Melbourne, Australia Business: Hematology, Supply/Service Chris Lieu CSL Ltd. Humanwell Healthcare...
BioCentury | Jun 13, 2017
Company News

CSL buying majority stake in Chinese plasma company

...Rui De Biological Products Co. Ltd. (Ruide) for $352 million. Ruide is a subsidiary of Humanwell Healthcare...
...16%. On Tuesday, CSL gained A$2.60 to A$137.65, and Humanwell added RMB0.44 to RMB19.47. Chris Lieu CSL Ltd. Humanwell Healthcare...
BioCentury | Aug 8, 2016
Financial News

Ambrx completes venture financing

...completed: 2016-08-04 Type: Venture financing Raised: $45 million Investors: Apricot Capital; Northeast Securities; Sinopharm Capital; Humanwell Healthcare...
BioCentury | Aug 4, 2016
Financial News

Ambrx raises $45M

...a financing round led by Apricot Capital and Northeast Securities Prosperity Healthcare Fund. Sinopharm Capital, Humanwell Healthcare...
BioCentury | Apr 18, 2016
Company News

Epic Pharma, Humanwell Healthcare Group, PuraCap Pharmaceutical LLC deal

...this quarter. The companies did not respond to inquiries. Epic Pharma LLC , Laurelton, N.Y. Humanwell Healthcare...
BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: S. aureus

...gel, approved to treat tinea pedis. TARGET/MARKER/PATHWAY: S. aureus staphyloxanthin LICENSING STATUS: Patented; licensed to Humanwell Healthcare...
BioCentury | Apr 13, 2015
Clinical News

Remimazolam: Phase III started

...and PendoPharm has exclusive rights in Canada. Hana Pharmaceutical Co. Ltd. , Seoul, South Korea Humanwell Healthcare...
BioCentury | Nov 3, 2014
Company News

International Medica, Humanwell Healthcare Group, Shanghai BravoBio deal

...in 1999 due to concerns of incidences of intussusception. International Medica Foundation , Rochester, Minn. Humanwell Healthcare...
BioCentury | Mar 26, 2012
Company News

Paion, Humanwell Healthcare Group deal

...Paion granted Yichang Humanwell Pharmaceutical Co. Ltd., a part of Humanwell Healthcare Group, an exclusive option to...
...Ltd. (Tokyo:4528; Osaka:4528, Osaka, Japan) has Japanese rights to remimazolam. Paion AG (Xetra:PA8), Aachen, Germany Humanwell Healthcare...
Items per page:
1 - 9 of 9